Full-thickness tissue engineered skin constructed with autogenic bone marrow mesenchymal stem cells

Area of Science:

• Regenerative Medicine
• Biomaterials Science
• Dermatology

Background:

• Clinical cutaneous deficiencies require effective regenerative therapies.
• Autologous stem cells offer a promising source for tissue engineering.
• Developing functional tissue-engineered skin is a key challenge.

Purpose of the Study:

• To investigate the feasibility of using autogenic bone marrow mesenchymal stem cells (BMSCs) for tissue-engineered skin.
• To differentiate BMSCs into epidermal and dermal cells in vitro.
• To assess the potential of engineered skin for clinical applications.

Main Methods:

• Isolation and in vitro differentiation of autogenic BMSCs into epidermal cells and fibroblasts.
• Induction using specific factors and biomaterials.
• Characterization via electron microscopy, surface marker analysis (CK19, CK10), and gene/protein expression assays (Collagen I, IL-6, IL-8).
• In vivo assessment of skin wound repair using BMSCs with scaffold materials.

Main Results:

• BMSCs successfully differentiated into epidermal-like cells with characteristic morphology and markers (CK19, CK10).
• Induced epidermal cells exhibited enhanced anti-radiation capacity (reduced UVB-induced apoptosis).
• Differentiated fibroblasts showed collagen deposition and expressed Collagen I mRNA, secreting IL-6 and IL-8.
• In vivo implantation of BMSCs with scaffolds significantly accelerated skin wound repair.

Conclusions:

• Autogenic BMSCs possess the potential to differentiate into both epidermal and dermal lineages in vitro.
• These differentiated cells demonstrate functional characteristics suitable for skin engineering.
• This study highlights the clinical feasibility of using autogenic BMSCs as seed cells for epidermis-like and dermis-like components in tissue-engineered skin grafts.